Successful Completion of ALS-6000-101 Sixth Dose Escalation and Clinical Update
Novacyt S.A. (AIM:NCYT) Completion of acquisition of Yourgene Health plc
The acquisition adds scale and diversification to create a stronger global diagnostics business, with a complementary suite of genomic technologies and services
Avacta Group PLC (AIM:AVCT) Notice of Results
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, will announce its unaudited interim results for the six months ended 30 June
Omega Diagnostics Gp (AIM:ODX) Directorate Change
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that Chris Lea, Group Finance Director of the Company, will be stepping down as
Abingdon Health PLC (AIM:ABDX) Salistick™ to be launched in Tesco
Salistick™, the first ever saliva pregnancy test, to be launched in Tesco
Yourgene Health PLC (AIM:YGEN) Rule 2.7 Announcement
RECOMMENDED CASH OFFER by Novacyt UK Holdings Limited (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc to be effected by means of a Scheme of Arrangement under Part
Avacta Group PLC (AIM:AVCT) Completion of Fifth Dose Escalation in AVA6000
Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study
Abingdon Health PLC (AIM:ABDX) Launch of Salistick™ saliva pregnancy test
Superdrug to sell Salistick™, the first ever saliva pregnancy test, initially in 400 stores and online Salistick™ also to launch on the Abingdon Simply Test website
Avacta Group PLC (AIM:AVCT) Statement regarding market speculation
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, notes the recent market speculation regarding possible fundraising.
Avacta Group PLC (AIM:AVCT) AGM and Shareholder Event Detailed Agenda
Avacta Annual General Meeting and Shareholder Event Detailed Agenda
Avacta Group PLC – Second Milestone in AffyXell Joint Venture
Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake